Sage Therapeutics Inc. (SAGE)
NASDAQ: SAGE
· Real-Time Price · USD
8.68
0.00 (0.00%)
At close: Jul 30, 2025, 3:59 PM
Sage Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 70.41M | 47.4M | 41.24M | 106.4M | 97.24M | 91.06M | 86.46M | 11.35M | 10.37M | 9.4M | 7.69M | 6.46M | 6.17M | 6.31M | 6.31M | 1.11B | 1.11B | 1.11B |
Cost of Revenue | 7.37M | 8.83M | 9.44M | 8.77M | 4.4M | 3.2M | 2.16M | 1.48M | 762K | 757K | 813K | 757K | 704K | 652K | 553K | 602K | 620K | 582K |
Gross Profit | 63.04M | 38.58M | 31.8M | 97.63M | 92.84M | 87.86M | 84.3M | 9.87M | 9.61M | 8.64M | 6.87M | 5.71M | 5.46M | 5.66M | 5.75M | 1.11B | 1.11B | 1.11B |
Operating Income | -324.82M | -382.15M | -431.77M | -371.65M | -482.3M | -541.46M | -579.85M | -691.68M | -621.31M | -579.26M | -546.99M | -518.57M | -507.99M | -487.6M | -460.91M | 638.55M | 662.29M | 631.34M |
Interest Income | 18.36M | 22.47M | 31.68M | 34.74M | 37.38M | 39.12M | 38.74M | 36.07M | 29.92M | 21.85M | 14.19M | 8.15M | 4.71M | 3.34M | 2.88M | 2.97M | 3.62M | 5.58M |
Pretax Income | -301.19M | -354.4M | -400.67M | -337.59M | -445.67M | -503.14M | -541.49M | -655.93M | -591.62M | -557.56M | -532.78M | -510.35M | -503.2M | -484.18M | -457.89M | 641.72M | 666.15M | 637.05M |
Net Income | -301.19M | -354.4M | -400.67M | -337.59M | -445.67M | -503.14M | -532.85M | -633.45M | -560.86M | -522.54M | -504.1M | -495.5M | -496.64M | -481.87M | -457.89M | 641.72M | 666.15M | 637.05M |
Selling & General & Admin | 227.45M | 221.44M | 215.82M | 216.29M | 241.21M | 260.79M | 274.52M | 286.74M | 270.08M | 246.93M | 227.7M | 211.97M | 199.19M | 190.13M | 183.5M | 185.4M | 171.79M | 166.67M |
Research & Development | 138.27M | 176.92M | 225.9M | 253.2M | 300.55M | 335.14M | 356.24M | 381.2M | 360.83M | 340.97M | 326.16M | 312.31M | 314.25M | 303.13M | 283.17M | 289.43M | 280.01M | 287.16M |
Other Expenses | 22.14M | 22.38M | 21.86M | -96K | -151K | -207K | -383K | -321K | -236K | -150K | 14K | 75K | 76K | 75K | 134K | 195K | 240K | 130K |
Operating Expenses | 387.86M | 420.73M | 463.57M | 469.49M | 541.76M | 595.94M | 630.76M | 667.95M | 630.92M | 587.9M | 553.86M | 524.28M | 513.45M | 493.26M | 466.66M | 474.83M | 451.8M | 453.83M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | -597K | -597K | -597K | -521K | 76K | 76K | 76K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 395.23M | 429.56M | 473.02M | 478.27M | 546.16M | 599.14M | 632.92M | 669.43M | 631.68M | 588.66M | 554.67M | 525.04M | 514.15M | 493.91M | 467.22M | 475.43M | 452.42M | 454.41M |
Income Tax Expense | n/a | n/a | 292.72K | 292.72K | 292.72K | 292.72K | -8.64M | -22.48M | -30.77M | -35.01M | -28.68M | -15.93M | -8.34M | -4.82M | -3.22M | -3.75M | -3.05M | -2.32M |
Shares Outstanding (Basic) | 62.61M | 61.86M | 60.77M | 61.12M | 60.54M | 60.14M | 59.99M | 59.91M | 59.77M | 59.67M | 59.49M | 59.43M | 59.27M | 58.96M | 58.9M | 58.82M | 58.58M | 58.37M |
Shares Outstanding (Diluted) | 62.61M | 61.86M | 60.77M | 61.12M | 60.54M | 60.14M | 59.99M | 59.91M | 59.77M | 59.67M | 59.49M | 59.43M | 59.27M | 59.03M | 58.9M | 58.82M | 58.58M | 58.37M |
EPS (Basic) | -4.9 | -5.81 | -6.6 | -5.58 | -7.42 | -8.4 | -8.92 | -10.61 | -9.41 | -8.79 | -8.5 | -8.38 | -8.42 | -8.19 | -7.8 | 13.03 | 13.21 | 12.41 |
EPS (Diluted) | -4.9 | -5.81 | -6.6 | -5.58 | -7.42 | -8.4 | -8.92 | -10.61 | -9.41 | -8.79 | -8.5 | -8.38 | -8.42 | -8.19 | -7.8 | 12.51 | 12.69 | 11.89 |
EBITDA | -302.96M | -359.86M | -409.74M | -371.41M | -448.13M | -507.26M | -545.07M | -656.8M | -620.09M | -578.09M | -545.87M | -517.41M | -506.73M | -485.73M | -456.73M | 642.92M | 666.4M | 663.63M |
EBIT | -302.68M | -359.78M | -410.52M | -372.46M | -449.51M | -508.67M | -546.46M | -658.08M | -621.31M | -579.29M | -547.02M | -518.61M | -508.02M | -487.6M | -460.91M | 638.42M | 661.63M | 659.09M |
Depreciation & Amortization | 600K | 807K | 1.03M | 1.31M | 1.39M | 1.41M | 1.39M | 1.27M | 1.22M | 1.17M | 1.12M | 1.17M | 1.29M | 1.91M | 4.21M | 4.53M | 4.78M | 4.54M |